SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BERYL DRUGS

BSE: 524606 22 Aug 2025
Healthcare
₹ 21.93
Beryl Drugs Ltd. specializes in Pharmaceuticals within the Healthcare sector.

BERYL DRUGS - Share Price & Details

Market Cap
₹11.4
High /Low
46.0 / 17.4
Stock P/E
49.5
Book Value
₹18.7
Dividend Yield
0.0
ROCE
10.1
ROE
₹6.3
Face Value
10.0
PEG Ratio
1.17
EVEBITDA
₹6.66
Debt
4.08
CMP / FCF
20.6
Debt to equity
₹0.43
NP Ann
0.58
High price all time
53.0
Piotroski score
₹7.0
Graham Number
13.8
No. Eq. Shares
0.51
Net CF
₹0.69
Net profit
0.23
Price to book value
1.21
Interest Coverage
₹2.05
Low price all time
0.72
Industry PE
32.8
Reserves
₹4.41
Free Cash Flow
₹0.45

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
BERYL DRUGS LTD.52.201.5239.740.3011.449.5
Cian Healthcare LimitedNANANANA10.3
ADLINE CHEM LAB LIMITED2.492.09NA0.0410.2

Peer Comparison Chart


About BERYL DRUGS

Beryl Drugs Ltd., with Security Code 524606, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Beryl Drugs Faces Challenges Amid Shift to Mildly Bearish Trend in Evaluation

(15 Aug 2025)
Beryl Drugs, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation amid a shift in market trends.
Read more →

Q1 results today: LIC, HPCL, Godrej Consumer Products among 233 on Aug 7

(07 Aug 2025)
Q1 FY26 company results, August 7: Bajaj Electricals, NBCC (India), Biocon, Edelweiss, Titan Company, and are also set to release their...
Read more →

Beryl Drugs Reports Mixed Financial Results, Highlights Profit Growth Amid Challenges in August 2025

(07 Aug 2025)
Beryl Drugs has announced its financial results for the quarter ending June 2025, showing a flat performance. The company reported a profit...
Read more →

Beryl Drugs standalone net profit declines 94.59% in the June 2025 quarter

(07 Aug 2025)
Net profit of Beryl Drugs declined 94.59% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.37 crore during the previous quarter ended June...
Read more →

Would You Accumulate or Wait on Beryl Drugs Limited (524606) - Consistently profitable trades

(26 Jul 2025)
【Investor Sentiment】✌️ Expert predictions of stock trends, real-time stock indices, metals, energy, and agricultural product data to guide...
Read more →

Can Beryl Drugs Limited (524606) Maintain Its Valuation - Unprecedented market success

(22 Jul 2025)
【Market Insights】✌️ Find the next big winner before the masses — our predictions have consistently uncovered 200%+ gainers early.
Read more →

Company Updates